Contraindications to vaccination
This adverse event (AE) constitutes an absolute contraindication to further administration of the study vaccines (10Pn-PD-DiT, Rotarix and Tritanrix-HepB/Hib); if this AE occurs during the study, the subject must not receive additional doses of the study vaccines but may continue other study procedures at the discretion of the investigator. The subject must be followed until resolution of the event, as with any AE.
boolean
Rectal temperature >= 38.0°C or oral/axillary/tympanic temperature >= 37.5°C. A temperature greater than or equal to these cut-offs warrants deferral of the vaccination pending recovery of the subject. These AEs constitute contraindications to administration of the study vaccines (10Pn-PD-DiT, Rotarix and Tritanrix-HepB/Hib) at that point in time; if any one of these AEs occur at the time scheduled for vaccination, the subject may be vaccinated at a later date, within the time window specified in the protocol, or withdrawn at the discretion of the investigator. The subject must be followed until resolution of the event, as with any AE:
boolean
Acute disease is defined as the presence of a moderate or severe illness with or without fever. All vaccines can be administered to persons with a minor illness such as diarrhoea or mild upper respiratory infections, provided the body temperature is <38°C (rectal measurement) or <37.5°C (for oral/axillary/tympanic measurements). The study visit should be postponed until the illness has improved. These AEs constitute contraindications to administration of the study vaccines (10Pn-PD-DiT, Rotarix and Tritanrix-HepB/Hib) at that point in time; if any one of these AEs occur at the time scheduled for vaccination, the subject may be vaccinated at a later date, within the time window specified in the protocol, or withdrawn at the discretion of the investigator. The subject must be followed until resolution of the event, as with any AE.
boolean
In these circumstances pertussis vaccination should be discontinued and the vaccination course should be continued with diphtheria-tetanus, hepatitis B, and Hib vaccines. The following adverse event constitutes an absolute contraindication to administration of the DTPw-HBV/Hib vaccine; if this adverse event occurs during the study, the investigator must decide which vaccine to give to the subject for these antigens. Contraindication(s) to the administration of the DTPw-HBV/Hib vaccine does not constitute contraindication to the administration of the pneumococcal vaccine. Children who will not receive the DTPw- HBV/Hib vaccine may still receive the study pneumococcal vaccine: the decision is left to the discretion of the investigator.
boolean
N.B. Contraindication(s) to the administration of the HRV vaccine does not constitute contraindication to the administration of the pneumococcal vaccine. Children who will not receive the HRV vaccine may still receive the study pneumococcal vaccine: the decision is left to the discretion of the investigator.
boolean
N.B. Contraindication(s) to the administration of the HRV vaccine does not constitute contraindication to the administration of the pneumococcal vaccine. Children who will not receive the HRV vaccine may still receive the study pneumococcal vaccine: the decision is left to the discretion of the investigator.
boolean
Tritanrix-HepB/Hib Warnings and Precautions
Axillary or oral temperature of >= 40°C or rectal temperature >= 40.5°C within 48 hours of vaccination, not due to another identifiable cause.
boolean
Collapse or shock-like state (hypotonic-hyporesponsive episode) within 48 hours of vaccination
boolean
Persistent crying lasting >= 3 hours, occurring within 48 hours of vaccination.
boolean
Convulsions with or without fever, occurring within 3 days of vaccination
boolean
Rotarix vaccine warnings and precautions
Administration of Rotarix postponed in case of diarrhoea/vomiting
boolean
Vaccination administration
Please fill in this repeating Itemgroup for each vaccine administered on that day. The 10Pn-PD-DiT vaccine is administered at Visits 1 (all cohorts), 2 (all cohorts except the 2+1 schedule HIV-neg. cohort), 3 (all cohorts) and 5 (all cohorts except the EPI/3+0 schedule HIV-neg. cohort). The DTPw-HBV/Hib vaccine is administered at Visits 1, 2, 3 and 8 (all cohorts). The HRV vaccine is administered at Visits 2 and 3, but only if Amendment 1 / Amendment 2 ICF has been signed before or on the day of the Visit.
integer
If not administered please give the major reason and provide who took the decision. Vaccine as planned: see item "Vaccine"
text
Replacement vial
integer
Wrong vial number
integer
If no please select all following items that apply. For the HRV vaccine (if applicable), only give a comment in case of "no". The side/site route for 10Pn-PD-DiT Vaccine: right thigh i.m. The side/site route for DTPw-HBV/Hib Vaccine: left thigh i.m. The route for HRV vaccine is oral.
boolean
if not according to protocol
text
if not according to protocol
integer
if not according to protocol
text
if administration not according to protocol
text
If SAE, please complete and submit SAE report, and specify SAE No. If AE, please complete Non-serious Adverse Event section, and specify AE No. If Other Reason, please specify
text
if SAE major reason for non-administration
integer
if AE major reason for non-administration
integer
e.g.: consent withdrawal, Protocol violation, …
text
Who made non-administration decision
text